Skip to main content
Signal8

Hewes L. Becker

SEC insider (Form 3/4/5 filer). CIK 0001840110. Chief Medical Officer at Galecto, Inc. (GLTO) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Jan 5, 2026. Located in WALTHAM, MA.

Companies Hewes L. Becker has filed insider reports for

  • Galecto, Inc. (GLTO): Officer, Chief Medical Officer
  • Blueprint Medicines Corp (BPMC): Officer, CHIEF MEDICAL OFFICER
Hewes L. Becker profile photo

Hewes L. Becker

CIK: 0001840110

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (37.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Galecto, Inc. logo
GLTO

Galecto, Inc.

Officer
Blueprint Medicines Corp logo
BPMC

Blueprint Medicines Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Galecto, Inc. logo
    GLTO

    Galecto, Inc.

    Jan 5, 2026
    Award
    Direct
    264.6K shares-
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Jul 17, 2025
    Award
    Direct
    21.4K shares-
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Jul 17, 2025
    Disposition
    Direct
    50.2K shares-
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Jul 17, 2025
    Tender Offer
    Direct
    1.6K shares-
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Mar 6, 2025
    Sale
    Direct
    2.7K shares at avg. $87.42$235K
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Mar 6, 2025
    Sale
    Direct
    2.5K shares at avg. $87.98$224K
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Mar 5, 2025
    Sale
    Direct
    4.9K shares at avg. $88.80$432K
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Mar 1, 2025
    Award
    Direct
    11K shares-

1-8 of 8